mRNA |
Panobinostat |
CCLE |
pan-cancer |
AAC |
-0.091 |
0.03 |
mRNA |
JNJ-26854165 |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.03 |
mRNA |
AZD0530 |
CCLE |
pan-cancer |
AAC |
-0.1 |
0.03 |
mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.03 |
mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.08 |
0.03 |
mRNA |
rigosertib |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.03 |
mRNA |
Crizotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |